Blue Laser Fusion, Inc.
Blue Laser Fusion filed its Q3 FY2026 10-Q, the first quarterly report following its September 4, 2026 reverse merger with SPAC Unite Acquisition 2 Corp. The company reported $28,000 in revenue (vs. $0 YoY), a net loss of $1.97M ($0.43/share), and held $33.0M in cash after closing a private placement of 1.24M shares at $27.50/share. R&D expenses dropped 47% YoY to $1.2M due to lower prototype build costs.
- Revenue of $28,000 in Q3 2026 vs. $0 in Q3 2025, from ratable recognition under a collaboration agreement that began April 1, 2026.
- Net loss narrowed to $1.97M ($0.43/share) from $2.45M ($0.70/share) YoY, a 20% improvement.
- R&D expenses fell 47% YoY to $1.2M, driven by ~$2.7M lower prototype build costs versus the prior-year period.
- Cash and cash equivalents surged to $33.0M at September 30, 2026 from $16.5M at December 31, 2025, reflecting the merger and private placement.
- The company completed its reverse merger with Unite Acquisition 2 Corp. on September 4, 2026, and raised ~$34.1M via a private placement at $27.50/share.
Price data unavailable.
First public financials post-reverse-merger reveal a deep-tech startup with negligible revenue, heavy R&D burn, and $33M cash — a classic high-risk, long-timeline fusion play now accessible to public investors.
Blue Laser Fusion is a pre-revenue deep-tech startup targeting directed-energy defense and inertial confinement fusion — adjacent to peers like Nuburu and Marvel Fusion. The reverse merger and $33M cash position provide a runway but the company remains years from commercial product.
The company has minimal revenue ($57K YTD) and an accumulated deficit of $27.6M, with operating losses expected to continue as it pursues capital-intensive directed-energy and fusion R&D. It warns that additional capital will be needed and there is no assurance of securing it on acceptable terms.